RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Toomey, Sinead, Eustace, Alex J., Pritzker, Laura B., Pritzker, Ken P. H., Fay, Joanna, O’Grady, Anthony, Cummins, Robert, Grogan, Liam, Kennedy, John, O’Connor, Darran, Young, Leonie, Kay, Elaine W.,Том:
108
Мова:
english
Журнал:
Journal of the National Cancer Institute
DOI:
10.1093/jnci/djw111
Date:
August, 2016
Файл:
PDF, 775 KB
english, 2016
File converter
Більше результатів пошуку
More benefits 
